A Novel Approach to Successful ABO-Incompatible High-Titer Renal Transplantation
Authors:
- 1 September 2008
- journal article
- Published by Elsevier in Transplantation Proceedings
- Vol. 40 (7) , 2285-2288
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- A Comparison of Splenectomy versus Intensive Posttransplant Antidonor Blood Group Antibody Monitoring without Splenectomy in ABO-Incompatible Kidney TransplantationTransplantation, 2005
- Is Administration of Rituximab at 375 mg/m2 Without Splenectomy Appropriate for ABO‐Incompatible Renal Transplant?American Journal of Transplantation, 2005
- Lack of Correlation between Results of ABO-Incompatible Living Kidney Transplantation and Anti-ABO Blood Type Antibody Titers under Our Current ImmunosuppressionTransplantation, 2005
- A new concept of accommodation in ABO‐incompatible kidney transplantationClinical Transplantation, 2005
- Improved Outcomes after ABO-Incompatible Living-Donor Kidney Transplantation after 4 Weeks of Treatment with Mycophenolate MofetilTransplantation, 2005
- ABO Incompatible High‐Titer Renal Transplantation without Splenectomy or Anti‐CD20 TreatmentAmerican Journal of Transplantation, 2005
- ABO-Incompatible Kidney TransplantationTransplantation, 2004
- Preconditioning regimen consisting of anti‐CD20 monoclonal antibody infusions, splenectomy and DFPP‐enabled non‐responders to undergo ABO‐incompatible kidney transplantationClinical Transplantation, 2004
- Excellent Long-term Outcome of ABO-Incompatible Living Donor Kidney Transplantation in JapanAmerican Journal of Transplantation, 2004
- Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics1Transplantation, 2004